Report

TABLE OF CONTENTS
1 INTRODUCTION 60
1.1 OBJECTIVES OF THE STUDY 60
1.2 MARKET DEFINITION 60
1.3 OVERVIEW OF GLOBAL BIOSTIMULANTS MARKET 60
1.4 CURRENCY AND PRICING 62
1.5 LIMITATIONS 62
1.6 MARKETS COVERED 63
2 MARKET SEGMENTATION 69
2.1 MARKETS COVERED 69
2.2 GEOGRAPHICAL SCOPE 70
2.3 YEARS CONSIDERED FOR THE STUDY 71
2.4 DBMR TRIPOD DATA VALIDATION MODEL 72
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 75
2.6 DBMR MARKET POSITION GRID 76
2.7 VENDOR SHARE ANALYSIS 77
2.8 MULTIVARIATE MODELING 78
2.9 ORIGIN TIMELINE CURVE 79
2.10 MARKET END-USER COVERAGE GRID 80
2.11 SECONDARY SOURCES 81
2.12 ASSUMPTIONS 81
3 EXECUTIVE SUMMARY 82
4 PREMIUM INSIGHTS 87
4.1 PORTER'S FIVE FORCES ANALYSIS 90
4.1.1 THREAT OF NEW ENTRANTS 90
4.1.2 BARGAINING POWER OF SUPPLIERS 91
4.1.3 BARGAINING POWER OF BUYERS 91
4.1.4 THREAT OF SUBSTITUTE PRODUCTS 91
4.1.5 INDUSTRY RIVALRY 92
4.2 PRICING ANALYSIS 93
4.3 COMPANY PRODUCTION CAPACITY OUTLOOK 94
4.3.1 OVERVIEW 94
4.3.2 CONCLUSION 95
4.4 INDUSTRY ECO-SYSTEM ANALYSIS 96
4.4.1 OVERVIEW 96
?
4.4.2 PROMINENT COMPANIES 96
4.4.2.1 GLOBAL SCALE AND STRATEGIC ADVANTAGES 96
4.4.2.2 KEY FUNCTIONS AND VALUE?CHAIN ROLES 96
4.4.3 SMALL & MEDIUM?SIZED COMPANIES 96
4.4.3.1 INNOVATION?DRIVEN SMES 96
4.4.3.2 BUSINESS MODELS AND COMPETITIVE ROLES 96
4.4.4 END USERS 97
4.4.4.1 SEGMENTATION OF END USERS 97
4.4.4.2 ADOPTION DRIVERS, BARRIERS AND VALUE CREATION 97
4.4.4.3 END?USER TABLE BY CROP SEGMENT 97
4.4.5 CONCLUSION 97
4.5 PATENT ANALYSIS- GLOBAL BIOSTIMULANTS MARKET 98
4.5.1 PATENT QUALITY AND STRENGTH 98
4.5.2 PATENT FAMILIES 98
4.5.3 LICENSING AND COLLABORATIONS 98
4.5.4 REGION PATENT LANDSCAPE 99
4.5.5 IP STRATEGY AND MANAGEMENT 100
4.6 RAW MATERIAL SOURCING 100
4.6.1 SEAWEED EXTRACTS 100
4.6.2 HUMIC AND FULVIC SUBSTANCES 101
4.6.3 AMINO ACIDS AND PROTEIN HYDROLYSATES 101
4.6.4 MICROBIAL STRAINS (BACTERIA, FUNGI, AND YEAST) 101
4.6.5 ORGANIC ACIDS AND POLYSACCHARIDES 102
4.6.6 INORGANIC NUTRIENTS AND CHELATING AGENTS 102
4.6.7 CARRIERS AND FORMULATION ADDITIVES 102
4.7 FACTORS AFFECTING BUYING DECISIONS IN THE GLOBAL BIOSTIMULANTS MARKET 103
4.7.1 INTRODUCTION: 103
4.7.2 PROVEN TECHNICAL EFFICACY AND DEMONSTRATED PERFORMANCE 103
4.7.3 CROP, SOIL, AND ENVIRONMENTAL FIT 103
4.7.4 ECONOMIC VIABILITY AND RETURN ON INVESTMENT (ROI) 103
4.7.5 TRUST, TRANSPARENCY, AND BRAND REPUTATION 104
4.7.6 REGULATORY COMPLIANCE AND SUSTAINABILITY CREDENTIALS 104
4.7.7 KNOWLEDGE, AWARENESS, AND RISK PERCEPTION 105
4.7.8 CONCLUSION 105
4.8 PRODUCTION CONSUMPTION ANALYSIS 106
4.8.1 PRODUCTION DATASET 106
4.8.2 CONSUMPTION DATASET 108
4.9 IMPORT EXPORT SCENARIO 109
4.9.1 IMPORT DATASET 109
4.9.2 EXPORT DATASET 110
4.10 INNOVATION TRACKER AND STRATEGIC ANALYSIS 112
4.10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 112
4.10.1.1 JOINT VENTURES 112
4.10.1.2 MERGERS & ACQUISITIONS 112
4.10.1.3 LICENSING & PARTNERSHIP AGREEMENTS 112
4.10.1.4 TECHNOLOGY COLLABORATIONS 112
4.10.1.5 STRATEGIC DIVESTMENTS / PORTFOLIO RESTRUCTURING 112
4.10.2 NUMBER OF PRODUCTS IN DEVELOPMENT 112
4.10.3 STAGE OF DEVELOPMENT 113
4.10.4 TIMELINES AND MILESTONES 113
4.10.5 INNOVATION STRATEGIES AND METHODOLOGIES 113
4.10.6 RISK ASSESSMENT AND MITIGATION 114
4.11 PRODUCT ADOPTION SCENARIO IN THE GLOBAL BIOSTIMULANTS MARKET 115
4.11.1 INTRODUCTION 115
4.11.2 CURRENT STAGE OF ADOPTION 115
4.11.3 REGIONAL AND CROP-SPECIFIC ADOPTION PATTERNS 115
4.11.4 DRIVERS OF ADOPTION 115
4.11.5 BARRIERS TO ADOPTION 116
4.11.6 ADOPTION CURVE AND OUTLOOK 116
4.11.7 FARMER-CENTRIC PERSPECTIVE 116
4.11.8 IMPLICATIONS FOR STAKEHOLDERS 116
4.11.9 CONCLUSION 116
4.12 COMPANY EVALUATION QUADRANT 117
4.13 COST ANALYSIS BREAKDOWN 118
4.13.1 OVERVIEW 118
4.13.2 CAPITAL INVESTMENT AND PRODUCTION SCALE 118
4.13.2.1 PLANT SCALE, INFRASTRUCTURE AND AUTOMATION 118
4.13.2.2 EQUIPMENT AND PROCESS COMPLEXITY 118
4.13.3 RAW MATERIAL, FORMULATION AND OPERATING COSTS 118
4.13.3.1 RAW MATERIAL SOURCING AND VARIABILITY 118
4.13.3.2 PROCESSING INTENSITY AND FORMULATION COMPLEXITY 118
4.13.3.3 VARIABILITY AND RISK PREMIUMS 118
4.13.4 REGULATORY, COMPLIANCE AND REGISTRATION COSTS 119
4.13.4.1 REGULATORY LANDSCAPE AND ASSOCIATED COSTS 119
4.13.4.2 IMPLICATIONS FOR MANUFACTURING COST BASE 119
4.13.5 LOGISTICS, DISTRIBUTION AND APPLICATION COSTS 119
4.13.5.1 PACKAGING, STORAGE AND TRANSPORTATION 119
4.13.5.2 CHANNEL STRUCTURE AND END?USER APPLICATION 119
4.13.6 COST?BENEFIT CONSIDERATIONS AND MARGIN IMPLICATIONS 119
4.13.6.1 RETURN?ON?INVESTMENT FOR GROWERS 119
4.13.6.2 MANUFACTURER AND DISTRIBUTOR MARGINS 119
4.13.7 COST?REDUCTION OPPORTUNITIES AND INDUSTRY TRENDS 120
4.13.7.1 USE OF AGRO?WASTE FEEDSTOCKS AND CIRCULAR ECONOMY 120
4.13.7.2 SCALE?UPS, PROCESS EFFICIENCY AND STANDARDISATION 120
4.13.7.3 REGULATORY HARMONISATION AND GLOBAL MARKET ACCESS 120
4.13.8 CONCLUSION 120
4.14 PROFIT MARGINS SCENARIO 121
4.14.1 OVERVIEW 121
4.14.2 VALUE?CHAIN MARGIN STRUCTURE 121
4.14.2.1 MANUFACTURER GROSS MARGIN 121
4.14.2.2 DISTRIBUTOR / DEALER MARGIN 121
4.14.2.3 FARMER VALUE?CAPTURE AND MARGIN REALISATION 121
4.14.3 MARGIN DRIVERS AND CONSTRAINTS 121
4.14.3.1 NOVEL ACTIVES AND PREMIUM PRICING 121
4.14.3.2 COST BASE PRESSURES 121
4.14.3.3 SCALE AND ADOPTION RATE 121
4.14.3.4 COMPETITIVE PRESSURE AND SUBSTITUTION 122
4.14.3.5 FARMER ROI AND WILLINGNESS TO PAY 122
4.14.4 ESTIMATED PROFIT MARGIN RANGES 122
4.14.5 MARGIN IMPROVEMENT STRATEGIES 122
4.14.5.1 VALUE?BASED PRICING 122
4.14.5.2 COST BASE OPTIMISATION 122
4.14.5.3 PREMIUM SEGMENT FOCUS 122
4.14.5.4 SCALE EXPANSION 123
4.14.5.5 FARMER ENGAGEMENT AND DEMONSTRATION 123
4.14.6 REGIONAL AND CROP?SEGMENT CONSIDERATIONS 123
4.14.7 CONCLUSION 123
4.15 IMPACT OF ECONOMIC SLOWDOWN ON MARKET 124
4.15.1 IMPACT ON PRICE 124
4.15.2 IMPACT ON SUPPLY CHAIN 124
4.15.3 IMPACT ON SHIPMENT 124
4.15.4 IMPACT ON COMPANY'S STRATEGIC DECISIONS 124
4.15.5 IMPACT ON DEMAND 125
4.15.6 IMPACT ON STRATEGIC DECISIONS 125
4.16 SUPPLY CHAIN ANALYSIS 126
4.16.1 OVERVIEW 126
4.16.2 LOGISTICS COST SCENARIO 126
4.16.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 127
?
5 TARIFFS & IMPACT ON THE MARKET 128
5.1 CURRENT TARIFF RATE 128
5.1.1 OUTLOOK: LOCAL PRODUCTION VS IMPORT RELIANCE 128
5.2 VENDOR SELECTION CRITERIA DYNAMICS 128
5.3 IMPACT ON SUPPLY CHAIN 129
5.3.1 RAW MATERIAL PROCUREMENT 129
5.3.2 MANUFACTURING AND PRODUCTION 129
5.3.3 LOGISTICS AND DISTRIBUTION 129
5.3.4 PRICE PITCHING AND POSITION OF MARKET 130
5.4 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 130
5.4.1 SUPPLY CHAIN OPTIMIZATION 130
5.4.2 JOINT VENTURE ESTABLISHMENTS 130
5.5 IMPACT ON PRICES 130
5.6 REGULATORY INCLINATION 131
5.6.1 GEOPOLITICAL SITUATION 131
5.6.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES 131
5.6.2.1 FREE TRADE AGREEMENTS 131
5.6.2.2 ALLIANCES ESTABLISHMENTS 131
5.6.3 STATUS ACCREDITATION (INCLUDING MFN) 131
5.6.4 DOMESTIC COURSE OF CORRECTION 132
5.6.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 132
5.6.4.2 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES / INDUSTRIAL PARKS 132
6 REGULATION COVERAGE IN THE GLOBAL BIOSTIMULANTS MARKET 133
6.1 OVERVIEW 133
6.2 REGULATORY DEFINITIONS AND CLASSIFICATION 133
6.3 COMPLIANCE AND REGISTRATION REQUIREMENTS 133
6.4 REGIONAL REGULATORY HIGHLIGHTS 133
6.5 IMPLICATIONS FOR STAKEHOLDERS 133
6.6 CHALLENGES IN REGULATORY COVERAGE 134
6.7 OUTLOOK 134
7 MARKET OVERVIEW 135
7.1 DRIVERS 137
7.1.1 INCREASING FREQUENCY OF CLIMATE-RELATED CROP STRESS SUCH AS DROUGHTS, FLOODS, AND HEAT WAVES IS DRIVING FARMERS TO ADOPT BIOSTIMULANTS TO MAINTAIN CROP YIELD AND QUALITY. 137
7.1.2 RISING GLOBAL DEMAND FOR ORGANIC AND SUSTAINABLY PRODUCED FOOD IS ENCOURAGING THE USE OF BIOSTIMULANTS AS A NATURAL ALTERNATIVE TO CHEMICAL FERTILIZERS. 137
7.1.3 DECLINING SOIL FERTILITY DUE TO OVERUSE OF SYNTHETIC FERTILIZERS AND INTENSIVE FARMING PRACTICES IS PROMPTING FARMERS TO USE BIOSTIMULANTS TO ENHANCE NUTRIENT ABSORPTION AND SOIL MICROBIAL ACTIVITY. 138
7.1.4 GROWING AWARENESS AMONG FARMERS ABOUT LONG-TERM SOIL HEALTH AND SUSTAINABLE AGRICULTURE IS INCREASING THE ADOPTION OF BIOSTIMULANTS TO IMPROVE PLANT RESILIENCE AND PRODUCTIVITY. 139
7.2 RESTRAINTS 140
7.2.1 HIGH COST OF BIOSTIMULANT PRODUCTS COMPARED TO CONVENTIONAL FERTILIZERS LIMITS ADOPTION AMONG SMALL-SCALE AND RESOURCE-CONSTRAINED FARMERS 140
7.2.2 INCONSISTENT PERFORMANCE ACROSS DIFFERENT CROPS, SOILS, AND CLIMATES CREATES UNCERTAINTY FOR FARMERS, SLOWING WIDESPREAD ADOPTION. 141
7.3 OPPORTUNITY 142
7.3.1 EXPANSION INTO EMERGING MARKETS WITH INCREASING AGRICULTURAL MODERNIZATION AND AWARENESS OF SUSTAINABLE PRACTICES PRESENTS SIGNIFICANT GROWTH POTENTIAL 142
7.3.2 DEVELOPMENT OF NEXT-GENERATION BIOSTIMULANTS (MICROBIAL, SEAWEED, OR AMINO ACID-BASED) TAILORED TO SPECIFIC CROPS AND STRESS CONDITIONS OFFERS OPPORTUNITIES FOR PRODUCT DIFFERENTIATION. 142
7.3.3 INTEGRATION OF BIOSTIMULANTS WITH PRECISION AGRICULTURE TECHNIQUES (LIKE SENSOR-BASED NUTRIENT MANAGEMENT AND TARGETED APPLICATION) CAN OPTIMIZE EFFICACY AND REDUCE INPUT COSTS 143
7.4 CHALLENGES 144
7.4.1 LACK OF STANDARDIZED QUALITY BENCHMARKS AND REGULATIONS GLOBALLY MAKES IT DIFFICULT TO ENSURE CONSISTENT PRODUCT EFFECTIVENESS, IMPACTING FARMER TRUST. 144
7.4.2 FRAGMENTED DISTRIBUTION NETWORKS AND LIMITED AVAILABILITY IN REMOTE AGRICULTURAL REGIONS RESTRICT MARKET PENETRATION AND CONSISTENT USAGE 145
8 GLOBAL BIOSTIMULANTS MARKET, BY ORIGIN 146
8.1 OVERVIEW 147
8.2 NATURAL BIOSTIMULANTS 149
8.2.1 LIQUID 150
8.2.2 DRY 150
8.3 SYNTHETIC BIOSTIMULANTS 151
8.3.1 LIQUID 152
8.3.2 DRY 152
9 GLOBAL BIOSTIMULANTS MARKET, BY FORM 153
9.1 OVERVIEW 154
9.2 LIQUID 155
9.3 DRY 156
10 GLOBAL BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENTS 158
10.1 OVERVIEW 159
10.2 ACID BASED 161
10.3 EXTRACT BASED 162
10.4 PROTEIN HYDROLYSATES 163
10.5 MICROBIAL AMENDMENTS 164
10.6 CHITIN 165
10.7 CHITOSAN 165
10.8 B- VITAMINS 166
10.9 OTHERS 167
11 GLOBAL BIOSTIMULANTS MARKET, BY CROP 168
11.1 OVERVIEW 169
11.2 FRUITS & VEGETABLES 170
11.3 CEREALS & GRAINS 173
11.4 OILSEEDS & PULSES 175
11.5 TURF & ORNAMENTALS 177
11.6 OTHER CROPS 178
12 GLOBAL BIOSTIMULANTS MARKET, BY APPLICATION METHOD 179
12.1 OVERVIEW 180
12.2 FOLIAR TREATMENT 181
12.3 SOIL TREATMENT 182
12.4 SEED TREATMENT 183
13 GLOBAL BIOSTIMULANTS MARKET, BY END USER 184
13.1 OVERVIEW 185
13.2 FARMERS 186
13.3 RESEARCH INSTITUTES 187
14 GLOBAL BIOSTIMULANTS MARKET, BY REGION 188
14.1 OVERVIEW 189
14.2 EUROPE 200
14.2.1 SPAIN 212
14.2.2 ITALY 220
14.2.3 U.K. 228
14.2.4 FRANCE 236
14.2.5 GERMANY 244
14.2.6 NETHERLANDS 252
14.2.7 SWITZERLAND 260
14.2.8 RUSSIA 268
14.2.9 BELGIUM 276
14.2.10 TURKEY 284
14.2.11 POLAND 292
14.2.12 DENMARK 300
14.2.13 SWEDEN 308
14.2.14 NORWAY 316
14.2.15 REST OF EUROPE 324
14.3 NORTH AMERICA 333
14.3.1 U.S. 345
14.3.2 CANADA 353
14.3.3 MEXICO 361
14.4 ASIA PACIFIC 369
14.4.1 CHINA 380
14.4.2 INDIA 388
14.4.3 AUSTRALIA 396
14.4.4 JAPAN 404
14.4.5 INDONESIA 412
14.4.6 SOUTH KOREA 420
14.4.7 THAILAND 428
14.4.8 MALAYSIA 436
14.4.9 PHILIPPINES 444
14.4.10 SINGAPORE 452
14.4.11 NEW ZEALAND 460
14.4.12 REST OF ASIA-PACIFIC 468
14.5 SOUTH AMERICA 476
14.5.1 BRAZIL 487
14.5.2 ARGENTINA 495
14.5.3 REST OF SOUTH AMERICA 503
14.6 MIDDLE EAST AND AFRICA 512
14.6.1 SOUTH AFRICA 524
14.6.2 SAUDI ARABIA 532
14.6.3 UNITED ARAB EMIRATES (UAE) 540
14.6.4 EGYPT 549
14.6.5 ISRAEL 557
14.6.6 REST OF MIDDLE EAST & AFRICA 565
15 GLOBAL BIOSTIMULANTS MARKET: COMPANY LANDSCAPE 573
15.1 MANUFACTURER COMPANY SHARE ANALYSIS: GLOBAL 573
15.2 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 574
15.3 COMPANY SHARE ANALYSIS: NORTH AMERICA 575
15.4 COMPANY SHARE ANALYSIS: EUROPE 576
16 SWOT ANALYSIS 577
?
17 COMPANY PROFILE 578
17.1 NOVOZYMES A/S 578
17.1.1 COMPANY SNAPSHOT 578
17.1.2 REVENUE ANALYSIS 578
17.1.3 COMPANY SHARE ANALYSIS 579
17.1.4 PRODUCT PORTFOLIO 579
17.1.5 RECENT DEVELOPMENT 580
17.2 AJINOMOTO CO., INC. 581
17.2.1 COMPANY SNAPSHOT 581
17.2.2 REVENUE ANALYSIS 582
17.2.3 COMPANY SHARE ANALYSIS 582
17.2.4 PRODUCT PORTFOLIO 583
17.2.5 RECENT DEVELOPMENT 583
17.3 UPL 584
17.3.1 COMPANY SNAPSHOT 584
17.3.2 REVENUE ANALYSIS 585
17.3.3 COMPANY SHARE ANALYSIS 585
17.3.4 PRODUCT PORTFOLIO 586
17.3.5 RECENT DEVELOPMENT 586
17.4 SYNGENTA 587
17.4.1 COMPANY SNAPSHOT 587
17.4.2 COMPANY SHARE ANALYSIS 587
17.4.3 PRODUCT PORTFOLIO 588
17.4.4 RECENT DEVELOPMENT 588
17.5 BASF 589
17.5.1 COMPANY SNAPSHOT 589
17.5.2 REVENUE ANALYSIS 589
17.5.3 COMPANY SHARE ANALYSIS 590
17.5.4 PRODUCT PORTFOLIO 590
17.5.5 RECENT DEVELOPMENT 591
17.6 AG BIOTECH, INC. 592
17.6.1 COMPANY SNAPSHOT 592
17.6.2 PRODUCT PORTFOLIO 592
17.6.3 RECENT DEVELOPMENT 592
17.7 AGRICEN 593
17.7.1 COMPANY SNAPSHOT 593
17.7.2 PRODUCT PORTFOLIO 593
17.7.3 RECENT DEVELOPMENT 595
?
17.8 ATLANTICA AGRICOLA 596
17.8.1 COMPANY SNAPSHOT 596
17.8.2 PRODUCT PORTFOLIO 596
17.8.3 RECENT DEVELOPMENT 597
17.9 BAYER AG 598
17.9.1 COMPANY SNAPSHOT 598
17.9.2 REVENUE ANALYSIS 598
17.9.3 PRODUCT PORTFOLIO 599
17.9.4 RECENT DEVELOPMENT 599
17.10 BIOSTADT. 600
17.10.1 COMPANY SNAPSHOT 600
17.10.2 PRODUCT PORTFOLIO 600
17.10.3 RECENT DEVELOPMENT 601
17.11 COROMANDEL INTERNATIONAL LTD. 602
17.11.1 COMPANY SNAPSHOT 602
17.11.2 REVENUE ANALYSIS 603
17.11.3 PRODUCT PORTFOLIO 603
17.11.4 RECENT DEVELOPMENT 603
17.12 FMC CORPORATION 604
17.12.1 COMPANY SNAPSHOT 604
17.12.2 REVENUE ANALYSIS 604
17.12.3 PRODUCT PORTFOLIO 605
17.12.4 RECENT DEVELOPMENT 606
17.13 HAIFA NEGEV TECHNOLOGIES LTD. 607
17.13.1 COMPANY SNAPSHOT 607
17.13.2 PRODUCT PORTFOLIO 607
17.13.3 RECENT DEVELOPMENT 608
17.14 ILSA S.P.A. 609
17.14.1 COMPANY SNAPSHOT 609
17.14.2 PRODUCT PORTFOLIO 609
17.14.3 RECENT DEVELOPMENT 611
17.15 REKA 612
17.15.1 COMPANY SNAPSHOT 612
17.15.2 PRODUCT PORTFOLIO 612
17.15.3 RECENT DEVELOPMENT 613
17.16 TSTANES. 614
17.16.1 COMPANY SNAPSHOT 614
17.16.2 REVENUE ANALYSIS 614
17.16.3 PRODUCT PORTFOLIO 615
17.16.4 RECENT DEVELOPMENT 617
18 QUESTIONNAIRE 618
?